Autopsy report · NCT06153186

Flunarizine for Treatment Resistant Absence Epilepsy

“The enrollment wasn't as predicted. We didn't have enough numbers to show statistical significance.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 3 years 8 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of British Columbia

Sponsor type

University, hospital or other

Conditions

Childhood Absence Epilepsy; Juvenile Absence Epilepsy; Juvenile Myoclonic Epilepsy

Interventions

Flunarizine Hydrochloride

Participants

9

Sites

1

Countries

Canada

Trials that died the same way

• Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
  “Enrollment was too low to provide statistically significant data” (81% match in meaning)
• Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer
  “The enrollment was too low” (73% match in meaning)
• Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
  “This study was stopped due to poor enrollment numbers” (69% match in meaning)
• 30 Day Rehospitalization Risk in Hemodialysis Patients
  “Lack of enrollment as expected” (68% match in meaning)
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
  “low enrollment - data was not analyzed for this study” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.